FDA.reportPublic FDA data

24 HR amantadine 137 MG Extended Release Oral Capsule

RxCUI
1944370
RxNorm name
24 HR amantadine 137 MG Extended Release Oral Capsule
Display name
24 HR amantadine 137 MG Extended Release Oral Capsule
Full name
24 HR amantadine 137 MG Extended Release Oral Capsule
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:06

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
82ff865f-78f3-4c94-b6a9-727a54944b28amantadine 137 MG 24HR Extended Release Oral Capsule [PSN] · 24 HR amantadine 137 MG Extended Release Oral Capsule [SCD] · amantadine 137 MG (as amantadine HCl 170 MG) 24 HR Extended Release Oral Capsule [SY]317These highlights do not include all the information needed to use GOCOVRI ® safely and effectively. See full prescribing information for GOCOVRI ® . GOCOVRI ® (amantadine) extended-release capsules, for oral use Initial U.S. Approval: 196820251022
2bee0631-0028-1314-e063-6394a90aaaedamantadine 137 MG 24HR Extended Release Oral Capsule [PSN] · 24 HR amantadine 137 MG Extended Release Oral Capsule [SCD] · amantadine 137 MG (as amantadine HCl 170 MG) 24 HR Extended Release Oral Capsule [SY]36These highlights do not include all the information needed to use GOCOVRI ® safely and effectively. See full prescribing information for GOCOVRI ® . GOCOVRI ® (amantadine) extended-release capsules, for oral use Initial U.S. Approval: 196820260216